Democratizing hedge fund level analysis tools for everyone
| Name | Phapros Tbk. |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| PT. Kimia Farma Tbk | 56.77 | 56.77 |
| Public < 5% | 32.77 | 32.77 |
| Masrizal A. Syarief | 10.46 | 10.46 |
| Source | 2022 | 2021 |
|---|---|---|
| 3127 | PEHA | F2 |
| 3128 | PEHA | F2 |
| 3129 | PEHA | F2 |
| 3130 | PEHA | F2 |
| 3132 | PEHA | F2 |
| 3131 | PEHA | F2 |
| Region | 2022 | 2021 |
|---|---|---|
| 1869 | PEHA | F2 |
| 1870 | PEHA | F2 |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 0.27 | # 3 / 15 |
| EV_EBITDA | 10.24 | # 5 / 15 |
| PER | 24.10 | # 10 / 15 |
| PBV | 0.61 | # 1 / 15 |
| DER | 2.61 | # 10 / 15 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | 1.1312 | # 10 / 15 |
| ROA % | 0.7100000000000001 | # 11 / 15 |
| ROE % | 2.55 | # 12 / 15 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2023 | 13.37 | 2.1 |
| 2022 | 7.91 | 1.2 |
| 2021 | 23.09 | 2.1 |
| 2020 | 85.03 | 5.0 |
| 2019 | 110.26 | 10.3 |
| Timeframe | Performance |
|---|---|
| 1W % | -3.9 |
| 1Mo % | -0.7 |
| 3Mo % | -9.8 |
| 1Yr % | -5.1 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 14.94 | 52.43 T | 53.67 T | 34,651 B | 5,348 B | 3,508 B |
| SOHO | 57.58 | 33.76 T | 36.00 T | 10,566 B | 742 B | 587 B |
| SIDO | 14.43 | 15.75 T | 15.31 T | 3,639 B | 1,481 B | 1,091 B |
| TSPC | 8.35 | 12.67 T | 11.15 T | 13,512 B | 2,016 B | 1,515 B |
| PYFA | -9.55 | 4.67 T | 10.70 T | 2,747 B | -142 B | -488 B |
| MDLA | 8.92 | 3.45 T | 6.04 T | 14,788 B | 557 B | 386 B |